ALNY — Alnylam Pharmaceuticals, Inc. stock price, charts and financials

QT29Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
219.00
-1.33-0.60%
OverviewShort InterestFilings
ALNYQT29Alnylam Pharmaceuticals, Inc.·NASDAQ
219.00-0.60%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20263Initial statement of beneficial ownership
Jun 01, 2026144Notice of proposed sale of restricted securities
May 27, 20268-KCurrent report
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20264Statement of changes in beneficial ownership
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 30, 20268-KCurrent report
Apr 30, 202610-QQuarterly report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 07, 20264Statement of changes in beneficial ownership
Apr 07, 20263Initial statement of beneficial ownership
#1 / 25 of 430
Page
▼
/ 18